Pulmatrix Inc. held a special meeting on June 16, 2025, where stockholders voted on key proposals related to a merger agreement. The issuance of shares of Pulmatrix common stock and the resulting change of control from the merger were approved. An amendment to effect a reverse stock split of Pulmatrix's issued and outstanding common stock was also approved. Additionally, stockholders approved an amendment to increase the number of shares of Pulmatrix common stock authorized for issuance from 200,000,000 to 250,000,000.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pulmatrix Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-015249), on June 16, 2025, and is solely responsible for the information contained therein.